Comparisons of high-risk cervical HPV infections in Caribbean and US populations
2009

Comparisons of high-risk cervical HPV infections in Caribbean and US populations

Sample size: 393 publication Evidence: moderate

Author Information

Author(s): Camille C Ragin, Angela Watt, Nina Markovic, Clareann H Bunker, Robert P Edwards, Stacy Eckstein, Horace Fletcher, David Garwood, Susanne M Gollin, Maria Jackson, Alan L Patrick, M Smikle, Emanuela Taioli, Victor W Wheeler, Jacque B Wilson, N Younger, Norma McFarlane-Anderson

Primary Institution: University of Pittsburgh Graduate School of Public Health

Hypothesis

What is the prevalence and type-specific distribution of cervical HPV infections among cancer-free Caribbean and US women?

Conclusion

Caribbean and US-Black women have a higher prevalence of cervical HPV infections, which may contribute to higher cervical cancer rates in these populations.

Supporting Evidence

  • 35% of women from Tobago tested positive for HPV.
  • 84% of women from Jamaica tested positive for HPV.
  • 32% of US women tested positive for HPV.
  • Jamaican women had the highest prevalence of high-risk HPV infections at 53%.
  • US-Whites had a lower prevalence of HPV infections compared to Jamaican subjects.

Takeaway

This study found that women from the Caribbean and US-Black women have more HPV infections than US-White women, which could lead to more cases of cervical cancer.

Methodology

The study compared HPV prevalence and genotype distribution among women from Tobago, Jamaica, and the US, using standardized protocols for sample collection and HPV testing.

Potential Biases

The recruitment methods may have introduced selection bias, particularly in the US population.

Limitations

The study had a small sample size for the US population, which may limit the ability to detect significant differences.

Participant Demographics

The study included 212 women from Tobago, 99 from Jamaica, and 82 from the US, with varying ethnic backgrounds.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI for Caribbean HPV prevalence: 41.3–53.0

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1750-9378-4-S1-S9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication